Exagen Inc

-0.11 (-4.68%)
6:51:19 PM EDT: $2.40 +0.16 (+7.14%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)37.76M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$10.33 Million
Adjusted EPS-$0.46
See more estimates
10-Day MA$2.36
50-Day MA$2.50
200-Day MA$2.64
See more pivots

Exagen Inc Stock, NASDAQ:XGN

1261 Liberty Way, Suite C, Vista, California 92081
United States of America
Phone: +1.760.560.1501
Number of Employees: 204


Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.